Acellular Dermal Matrix Market

Acellular Dermal Matrix Market - Global Industry, Analysis, Size, Share, Growth, Trends, and Forecasts 2023-2030

Acellular dermal matrix is an allograft tissue that is chemically processed to remove all epidermal and dermal cells while preserving the remaining bioactive dermal matrix. Acellular dermal matrices refer to biologically derived products that are lacking cells. It works by providing a bioactive matrix consisting of collagens, elastin, blood vessel channels, and bioactive proteins that support revascularization, cell repopulation, and tissue remodeling. This material is considered to be a safe alternative to autograft since no cases of viral transmission have been reported in ten years of use in more than 500,000 grafts. FDA-approved ADM’s uses include root coverage, soft tissue, flap extension over bone graft, amalgam tattoo correction, and soft tissue defect repair.

Acellular dermal matrices are adopted in the management of injuries to soft tissues. These products have been increasingly employed for their clinical advantages and they are acquiring the future of plastic surgery. Nowadays matrix is widely used in plastic and breast surgery. Moreover, acellular dermal matrices are widely used in the management of acute wounds such as traumatic wounds, burns, infections, and cancers as well as in the management of chronic wounds such as pressure ulcers and others, venous leg ulcers, diabetic foot ulcers, and abdominal wall procedures such as hernia repair and other.

Global Acellular Dermal Matrix Market – Competitive Landscape

Acellular dermal matrix market size competitive landscape provides details and data information by players. Competitive Landscape for the global acellular dermal matrix market is extremely Intense. Several Players working in the global acellular dermal matrix market are investing extensively in research and development activities. In addition, many Players are focused on expanding their business by engaging in merger and acquisition activities. In 2023 Medtronic has entered into a set definitive agreement to Acquire Eoflow Co.Ltd.  A recent Acquisition of A&E Medical Corporation by Zimmer and Biomet. This move by Zimmer Biomet is expected to strengthen its position in the global acellular dermal matrices market during the forthcoming years.

Some of the Key players in the Global Acellular Dermal Matrix Market Include –

  • Medtronic
  • Straumann
  • Johnson and Johnson
  • Synthes
  • Integra Life Science Corporation
  • Zimmer Biomet
  • Aziyo Biologics
  • Smith and Nephew Plc

Global Acellular Dermal Matrix Market – Growth Drivers

The global acellular dermal matrix market is experiencing significant growth driven by a confluence of a factor. The demand for reconstructive surgery increases as the instances of trauma, congenital defects, and cancer-related surgeries have driven the demand for ADMs in reconstructive surgery. Ongoing Advancements in ADM technology result in better-quality products with enhanced safety and efficacy. Innovation in tissue processing, storage, and delivery methods contribute to market expansion. The global acellular dermal market is growing to owing the increasing prevalence of patients suffering from chronic conditions like cardiovascular disease, diabetes, and cancer—these conditions are currently a leading cause of death. The healthcare sector can provide ways of managing symptoms. The combination of ADMs with other medical technologies and increased patient awareness about their benefits are additional driving forces behind this market expansion.

Global Acellular Dermal Matrix Market – Restraints

The global acellular dermal matrix market has been experiencing rapid demand and adaptation across various key application and end-use sectors in recent years. However, the global economy, which has struggled since the pandemic, is forecasted to grow at a slower rate due to the Russia-Ukraine war, rising inflation, and growing interest rates. All these factors make consumers vary in purchasing, adversely impacting the manufacturing sector and overall market potential. The high cost of products and availability of alternatives is a key factor confining its demand and approval in several regions as well. According to National center for Biotechnology Information (NCBI) healthcare spending of per person is US$ 5,300 annually.

Covid-19 affected nearly every industry vertical. Due to nationwide lockdowns in most countries, including restrictions on the movement of goods and people. The COVID-19 pandemic affected the market dynamics across both developed regions as well as emerging economies. However, post-pandemic, all economies have experienced a gradual recovery, pushing the market on track

Global Acellular Dermal Matrix Market – Opportunities

To gain a competitive edge, acellular dermal matrix products meet regulatory standards and quality requirements. Exploring opportunities increases the demand for advanced medical treatments and regenerative solutions. Developing acellular dermal matrix market develop the different specific application, and patient needs, including personalized medicine approaches. Opportunities for acellular dermal matrix in various plastic and reconstructive surgeries such as facial reconstruction and body contorting.

Global Acellular Dermal Matrix Market – Geographical Insight

Geographically, the market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, Europe and Africa. Developed economies will continue to account for a larger proportion of the market but the growth in per capita income and economic growth in developing economies. Regulatory considerations are paramount in this market, with different regions having distinct regulatory frameworks necessitating a nuanced understanding by industry players. Look ahead, the ADM market promises continued growth, driven by innovative development, including the exploration of alternative sources for ADMs and their integration with regenerative medicine and tissue engineering cementing its significance in the evolving healthcare industry.

Global Acellular Dermal Matrix Market – Key Development

  • AlloSource, one of the largest allograft providers in the U.S. created innovative cellular and tissue products to help surgeons heal their patients in 2021 which was AlloMend® Ultra-Thick acellular dermal matrix, the newest addition to the AlloMend product line.
Complete the form below and we'll get back to you shortly
Table of Content
Complete the form below and we'll get back to you shortly
cognizance market research(cmr)

Acellular Dermal Matrix Market


Black Friday Offers (40% Off)​

Don’t Miss Out On The Biggest Savings Of The Year!

- Get Started -

Get insights that lead to new growth opportunities

Need a Custom Report?

We can customize every report – free of charge – including purchasing stand-alone sections or country-level reports

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Business Development

small c popup.png

Black Friday Offers (40% Off)

Don't miss out on the biggest savings of the year!

small c popup.png
Buy Now
small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
Ask an Expert